Annual total expenses:
$44.07B+$6.98B(+18.82%)Summary
- As of today (August 3, 2025), AZN annual total expenses is $44.07 billion, with the most recent change of +$6.98 billion (+18.82%) on December 31, 2024.
- During the last 3 years, AZN annual total expenses has risen by +$6.51 billion (+17.34%).
- AZN annual total expenses is now at all-time high.
Performance
AZN Total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly total expenses:
$10.95B+$1.03B(+10.44%)Summary
- As of today (August 3, 2025), AZN quarterly total expenses is $10.95 billion, with the most recent change of +$1.03 billion (+10.44%) on June 30, 2025.
- Over the past year, AZN quarterly total expenses has increased by +$757.00 million (+7.43%).
- AZN quarterly total expenses is now -18.88% below its all-time high of $13.50 billion, reached on December 31, 2021.
Performance
AZN Quarterly total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
AZN Total expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +18.8% | +7.4% |
| 3 y3 years | +17.3% | +7.0% |
| 5 y5 years | +94.6% | +119.4% |
AZN Total expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +18.8% | -14.8% | +27.7% |
| 5 y | 5-year | at high | +94.6% | -18.9% | +119.4% |
| alltime | all time | at high | +765.8% | -18.9% | +737.1% |
AZN Total expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $10.95B(+10.4%) |
| Mar 2025 | - | $9.91B(-22.9%) |
| Dec 2024 | $44.07B(+18.8%) | $12.86B(+12.2%) |
| Sep 2024 | - | $11.46B(+12.4%) |
| Jun 2024 | - | $10.19B(+6.6%) |
| Mar 2024 | - | $9.56B(-11.4%) |
| Dec 2023 | $37.09B(-6.9%) | $10.79B(+13.1%) |
| Sep 2023 | - | $9.54B(+6.5%) |
| Jun 2023 | - | $8.96B(+4.5%) |
| Mar 2023 | - | $8.57B(-7.8%) |
| Dec 2022 | $39.84B(+6.1%) | $9.30B(-4.5%) |
| Sep 2022 | - | $9.74B(-4.8%) |
| Jun 2022 | - | $10.23B(-2.7%) |
| Mar 2022 | - | $10.51B(-22.1%) |
| Dec 2021 | $37.56B(+65.4%) | $13.50B(+17.0%) |
| Sep 2021 | - | $11.54B(+62.7%) |
| Jun 2021 | - | $7.09B(+30.7%) |
| Mar 2021 | - | $5.42B(-24.3%) |
| Dec 2020 | $22.70B(+0.2%) | $7.17B(+32.6%) |
| Sep 2020 | - | $5.41B(+8.3%) |
| Jun 2020 | - | $4.99B(-2.8%) |
| Mar 2020 | - | $5.13B(-29.4%) |
| Dec 2019 | $22.65B(+5.0%) | $7.27B(+28.7%) |
| Sep 2019 | - | $5.65B(+6.0%) |
| Jun 2019 | - | $5.33B(+21.3%) |
| Mar 2019 | - | $4.39B(-47.7%) |
| Dec 2018 | $21.57B(+5.7%) | $8.40B(+89.9%) |
| Sep 2018 | - | $4.43B(+0.8%) |
| Jun 2018 | - | $4.39B(-2.0%) |
| Mar 2018 | - | $4.48B(-26.0%) |
| Dec 2017 | $20.41B(+5.1%) | $6.06B(+19.2%) |
| Sep 2017 | - | $5.08B(+23.2%) |
| Jun 2017 | - | $4.13B(-8.1%) |
| Mar 2017 | - | $4.49B(+43.9%) |
| Dec 2016 | $19.43B(-10.2%) | $3.12B(-33.2%) |
| Sep 2016 | - | $4.67B(-11.9%) |
| Jun 2016 | - | $5.30B(+4.4%) |
| Mar 2016 | - | $5.08B(-20.1%) |
| Dec 2015 | $21.64B(-10.4%) | $6.36B(+33.2%) |
| Sep 2015 | - | $4.78B(-11.3%) |
| Jun 2015 | - | $5.38B(+5.1%) |
| Mar 2015 | - | $5.12B(-18.4%) |
| Dec 2014 | $24.16B(+9.3%) | $6.28B(+3.5%) |
| Sep 2014 | - | $6.07B(+7.3%) |
| Jun 2014 | - | $5.65B(+0.5%) |
| Mar 2014 | - | $5.62B(-25.4%) |
| Dec 2013 | $22.11B(+10.1%) | $7.54B(+66.0%) |
| Sep 2013 | - | $4.54B(-9.7%) |
| Jun 2013 | - | $5.03B(+0.9%) |
| Mar 2013 | - | $4.99B(-10.6%) |
| Dec 2012 | $20.09B(-10.0%) | $5.58B(+23.3%) |
| Sep 2012 | - | $4.53B(-5.6%) |
| Jun 2012 | - | $4.79B(-7.7%) |
| Mar 2012 | - | $5.19B(-35.2%) |
| Dec 2011 | $22.31B(+2.7%) | $8.01B(+102.6%) |
| Sep 2011 | - | $3.95B(-27.7%) |
| Jun 2011 | - | $5.46B(+11.7%) |
| Mar 2011 | - | $4.89B(-20.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2010 | $21.72B(-0.4%) | $6.15B(+11.9%) |
| Sep 2010 | - | $5.49B(+6.8%) |
| Jun 2010 | - | $5.14B(+4.3%) |
| Mar 2010 | - | $4.93B(-31.2%) |
| Dec 2009 | $21.81B(-2.9%) | $7.17B(+43.6%) |
| Sep 2009 | - | $5.00B(-2.2%) |
| Jun 2009 | - | $5.11B(+12.5%) |
| Mar 2009 | - | $4.54B(-30.8%) |
| Dec 2008 | $22.46B(+4.6%) | $6.56B(+25.1%) |
| Sep 2008 | - | $5.24B(-2.0%) |
| Jun 2008 | - | $5.35B(+0.9%) |
| Mar 2008 | - | $5.30B(-22.5%) |
| Dec 2007 | $21.46B(+17.6%) | $6.84B(+37.4%) |
| Sep 2007 | - | $4.98B(+1.2%) |
| Jun 2007 | - | $4.92B(+4.5%) |
| Mar 2007 | - | $4.71B(-8.5%) |
| Dec 2006 | $18.26B(+4.6%) | $5.15B(+16.8%) |
| Sep 2006 | - | $4.41B(-1.9%) |
| Jun 2006 | - | $4.49B(+6.9%) |
| Mar 2006 | - | $4.20B(-9.6%) |
| Dec 2005 | $17.45B(+3.4%) | $4.65B(+13.6%) |
| Sep 2005 | - | $4.09B(-7.2%) |
| Jun 2005 | - | $4.41B(+2.9%) |
| Mar 2005 | - | $4.29B(-5.3%) |
| Dec 2004 | $16.88B(+13.7%) | $4.53B(+10.6%) |
| Sep 2004 | - | $4.09B(-3.4%) |
| Jun 2004 | - | $4.24B(+5.3%) |
| Mar 2004 | - | $4.02B(-2.6%) |
| Dec 2003 | $14.84B(+7.3%) | $4.13B(+12.2%) |
| Sep 2003 | - | $3.68B(+3.4%) |
| Jun 2003 | - | $3.56B(+2.7%) |
| Mar 2003 | - | $3.47B(-13.0%) |
| Dec 2002 | $13.84B(+12.3%) | $3.99B(+12.2%) |
| Sep 2002 | - | $3.55B(+9.4%) |
| Jun 2002 | - | $3.25B(+6.5%) |
| Mar 2002 | - | $3.05B(-9.0%) |
| Dec 2001 | $12.32B(-9.7%) | $3.35B(+14.1%) |
| Sep 2001 | - | $2.94B(-7.1%) |
| Jun 2001 | - | $3.16B(+7.0%) |
| Mar 2001 | - | $2.95B(-38.4%) |
| Dec 2000 | $13.64B(+16.6%) | $4.79B(+67.7%) |
| Sep 2000 | - | $2.86B(-4.9%) |
| Jun 2000 | - | $3.00B(+0.2%) |
| Mar 2000 | - | $3.00B(+129.0%) |
| Dec 1999 | $11.70B(+31.6%) | $1.31B(-61.2%) |
| Sep 1999 | - | $3.37B(-4.0%) |
| Jun 1999 | - | $3.51B(+40.2%) |
| Dec 1998 | $8.89B(+31.2%) | - |
| Jun 1998 | - | $2.51B(+52.9%) |
| Dec 1997 | $6.77B(-7.4%) | - |
| Dec 1996 | $7.32B(+24.3%) | - |
| Dec 1995 | $5.89B(+1.3%) | - |
| Jun 1995 | - | $1.64B |
| Dec 1994 | $5.81B(+4.7%) | - |
| Dec 1993 | $5.55B(+9.0%) | - |
| Dec 1992 | $5.09B(-16.3%) | - |
| Dec 1991 | $6.08B(+0.7%) | - |
| Dec 1990 | $6.04B | - |
FAQ
- What is AstraZeneca PLC annual total expenses?
- What is the all time high annual total expenses for AstraZeneca PLC?
- What is AstraZeneca PLC annual total expenses year-on-year change?
- What is AstraZeneca PLC quarterly total expenses?
- What is the all time high quarterly total expenses for AstraZeneca PLC?
- What is AstraZeneca PLC quarterly total expenses year-on-year change?
What is AstraZeneca PLC annual total expenses?
The current annual total expenses of AZN is $44.07B
What is the all time high annual total expenses for AstraZeneca PLC?
AstraZeneca PLC all-time high annual total expenses is $44.07B
What is AstraZeneca PLC annual total expenses year-on-year change?
Over the past year, AZN annual total expenses has changed by +$6.98B (+18.82%)
What is AstraZeneca PLC quarterly total expenses?
The current quarterly total expenses of AZN is $10.95B
What is the all time high quarterly total expenses for AstraZeneca PLC?
AstraZeneca PLC all-time high quarterly total expenses is $13.50B
What is AstraZeneca PLC quarterly total expenses year-on-year change?
Over the past year, AZN quarterly total expenses has changed by +$757.00M (+7.43%)